TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20441726

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 60

Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 60
Study: 18042053

Group type: EXPERIMENTAL
Intervention: rosuvastatin 10 mg
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: atorvastatin 20 mg
Number of subjects: 22
Study: 16089140

Group type: EXPERIMENTAL
Intervention: Modified shenqi fanghou recipe (SFR) as adjuvant to radiotherapy
Number of subjects: 140

Group type: COMPARATOR
Intervention: Radiotherapy alone (Control)
Number of subjects: 140
Study: 12095058

Group type: EXPERIMENTAL
Intervention: Alendronate 10mg/day
Number of subjects: 58

Group type: COMPARATOR
Intervention: Control (Group B)
Number of subjects: 58
Study: 10434812

Group type: EXPERIMENTAL
Intervention: Propofol (2.5 mg kg‐1 followed by 10‐6 mg kg‐1 h‐1)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Propofol-nitrous oxide
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Midazolam (0.3 mg kg‐1 followed by 0.15 mg kg‐1 h‐1)
Number of subjects: 30
Study: 7779222

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 2338118

Group type: EXPERIMENTAL
Intervention: Estramustine phosphate with milk
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Estramustine phosphate with food
Number of subjects: 6

Group type: COMPARATOR
Intervention: Estramustine phosphate with low calcium water
Number of subjects: 6
Study: 205633

Group type: EXPERIMENTAL
Intervention: Low dose ethanol treatment
Number of subjects: 18

Group type: COMPARATOR
Intervention: Chlordiazepoxide treatment
Number of subjects: 18
Study: 30767253

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 49

Group type: COMPARATOR
Intervention: Vildagliptin
Number of subjects: 49
Study: 27648814

Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study: 25844613

Group type: EXPERIMENTAL
Intervention: 20-week maintenance therapy with a cosmeceutical formulation containing hydroxyphenoxy propionic acid, ellagic acid, yeast extract, and salicylic acid
Number of subjects: 33
Study: 23844003

Group type: EXPERIMENTAL
Intervention: Dementia-care mapping (DCM) intervention conducted by trained nursing staff over 4 months.
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Dementia-care mapping (DCM) intervention
Number of subjects: 434

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 434
Study: 21296603

Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18585822

Group type: EXPERIMENTAL
Intervention: Death certificate data
Number of subjects: 237

Group type: EXPERIMENTAL
Intervention: Death certificates
Number of subjects: 237
Study: 16412857

Group type: EXPERIMENTAL
Intervention: 80 mg atorvastatin (ATV)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 15
Study: 15222854

Group type: EXPERIMENTAL
Intervention: Emotional words
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral words
Number of subjects: 0
Study: 11910619

Group type: COMPARATOR
Intervention: Esterified estrogens 0.3 mg daily (long-term study)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Esterified estrogens 0.3 mg daily (short-term study)
Number of subjects: 204
Study: 9057990

Group type: EXPERIMENTAL
Intervention: Intensive phototherapy with blue light
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intensive phototherapy with green light
Number of subjects: 10
Study: 8378661

Group type: EXPERIMENTAL
Intervention: Simvastatin (10 mg q.p.m. initially, increased to 40 mg q.p.m. for 64% of patients after 18 weeks)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Gemfibrozil (900 mg q.p.m.)
Number of subjects: 136
Study: 3796783

Group type: EXPERIMENTAL
Intervention: Very low protein intake (0.4 g/kg/day) supplemented with keto analogues of essential amino acids
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard low protein diet (0.6 g/kg/day)
Number of subjects: 19
Study: 31012563

Group type: EXPERIMENTAL
Intervention: 4% BPO cleanser
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: 10% BPO cleanser
Number of subjects: 133

Group type: COMPARATOR
Intervention: Reference product (10% BPO)
Number of subjects: 133
Study: 29125992

Group type: EXPERIMENTAL
Intervention: FVOO (500 ppm)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: FVOOT (500 ppm)
Number of subjects: 33

Group type: COMPARATOR
Intervention: VOO (80 ppm)
Number of subjects: 33
Study: 26935962

Group type: EXPERIMENTAL
Intervention: Extraction group (multiband treatment plus isolated extraction of mandibular teeth)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Non-extraction group (multiband treatment without extraction of teeth)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 46
Study: 25365567

Group type: EXPERIMENTAL
Intervention: Competitive game with a confederate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cooperative game with a confederate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Observation without playing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Players who lost the competition
Number of subjects: 0

Group type: COMPARATOR
Intervention: Players who won the competition
Number of subjects: 0
Study: 22644342

Group type: EXPERIMENTAL
Intervention: AST-120 2 g administered simultaneously with triazolam 0.25 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Triazolam 0.25 mg alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: AST-120 2 g administered 30 or 60 min before triazolam 0.25 mg
Number of subjects: 12
Study: 20053413

Group type: EXPERIMENTAL
Intervention: 48-hour drainage (Group I)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 96-hour drainage (Group II)
Number of subjects: 65
Study: 18853553

Group type: EXPERIMENTAL
Intervention: Observation of a dynamic object
Number of subjects: 0
Study: 15740547

Group type: EXPERIMENTAL
Intervention: Everolimus (1.5 or 3 mg/d)
Number of subjects: 779

Group type: COMPARATOR
Intervention: Cyclosporine (standard concentration range)
Number of subjects: 779
Study: 12194379

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 10407881

Group type: EXPERIMENTAL
Intervention: Lavender aromatherapy during recovery period
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no lavender aromatherapy) during recovery period
Number of subjects: 20
Study: 7750306

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP), 400 micrograms, two times daily
Number of subjects: 56
Study: 2248822

Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine with adrenaline 5 micrograms ml‐1
Number of subjects: 16

Group type: COMPARATOR
Intervention: 0.5% bupivacaine without adrenaline (plain bupivacaine)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both groups (with and without adrenaline)
Number of subjects: 16
Study: 7028536

Group type: EXPERIMENTAL
Intervention: Acipimox 150 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Acipimox 250 mg
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Acipimox 400 mg
Number of subjects: 6

Group type: COMPARATOR
Intervention: Food effect
Number of subjects: 6
Study: 30893217

Group type: EXPERIMENTAL
Intervention: Unilateral knees and randomly selected knees from the bilateral group (n = 217)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Males (n not specified)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Females (n not specified)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Right knees (n not specified)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Left knees (n not specified)
Number of subjects: 217
Study: 28654771

Group type: EXPERIMENTAL
Intervention: Cognitive‐Behavioral Group Therapy (CBGT)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Stress Reduction (MBSR)
Number of subjects: 108
Study: 26384729

Group type: EXPERIMENTAL
Intervention: Intramedullary nail fixation
Number of subjects: 320

Group type: COMPARATOR
Intervention: Plate and locking screw fixation
Number of subjects: 320
Study: 23428941

Group type: EXPERIMENTAL
Intervention: Low fat/energy condition
Number of subjects: 47

Group type: COMPARATOR
Intervention: Baseline condition
Number of subjects: 47

Group type: COMPARATOR
Intervention: High fat/energy condition
Number of subjects: 47
Study: 21352660

Group type: EXPERIMENTAL
Intervention: Nebulized bronchodilator + oxygen + forward‐leaning posture
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Nebulized bronchodilator + heliox + forward‐leaning posture
Number of subjects: 59

Group type: COMPARATOR
Intervention: Nebulized bronchodilator + heliox
Number of subjects: 59
Study: 19702064

Group type: EXPERIMENTAL
Intervention: New-design extended tip modified Ayre's spatula
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional modified Ayre's spatula
Number of subjects: 200
Study: 17355549

Group type: EXPERIMENTAL
Intervention: Active preparation (cannabis-based medicine containing THC and CBD)
Number of subjects: 189

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 189
Study: 15566533

Group type: EXPERIMENTAL
Intervention: Incognito standardised patients (SPs) as known patients
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Preparation of patient records for SP visits
Number of subjects: 49
Study: 11572286

Group type: EXPERIMENTAL
Intervention: Oral B 40
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Crest Spin Brush
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Colgate ActiBrush
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control (Manual Toothbrush)
Number of subjects: 104
Study: 9541513

Group type: EXPERIMENTAL
Intervention: Intranasal calcitonin 50 IU
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Intranasal calcitonin 100 IU
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Intranasal calcitonin 200 IU
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Intranasal calcitonin (all dosages)
Number of subjects: 30
Study: 7836548

Group type: EXPERIMENTAL
Intervention: Feeding with neo/chol
Number of subjects: 14

Group type: COMPARATOR
Intervention: Feeding in control Gilbert's patients
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Feeding in neo/chol‐treated normals
Number of subjects: 14

Group type: COMPARATOR
Intervention: Feeding in control normals
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Fasting and neo/chol in patients with Gilbert's syndrome
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Fed and control state in patients with Gilbert's syndrome
Number of subjects: 14
Study: 3278927

Group type: EXPERIMENTAL
Intervention: ATG plus Methenolone (3 mg/kg)
Number of subjects: 30

Group type: COMPARATOR
Intervention: ATG only
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Total population
Number of subjects: 30
Study: 29680277

Group type: EXPERIMENTAL
Intervention: Snodgrass repair
Number of subjects: 60

Group type: COMPARATOR
Intervention: Grafted tubularized incised plate repair (GTIP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Flow rate data
Number of subjects: 60

Group type: COMPARATOR
Intervention: Operative time
Number of subjects: 60
Study: 27896236

Group type: EXPERIMENTAL
Intervention: ISO-WHEY
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: BCAA
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (no nutritional supplement)
Number of subjects: 66
Study: 24789659

Group type: EXPERIMENTAL
Intervention: Long-axis technique
Number of subjects: 50

Group type: COMPARATOR
Intervention: Short-axis technique
Number of subjects: 50
Study: 22550938

Group type: EXPERIMENTAL
Intervention: Point-of-care measurement of BNP (n = 163)
Number of subjects: 323

Group type: COMPARATOR
Intervention: Standard assessment without BNP (n = 160)
Number of subjects: 323
Study: 20890856

Group type: EXPERIMENTAL
Intervention: TVT
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: TVT-O
Number of subjects: 187

Group type: EXPERIMENTAL
Intervention: TOT
Number of subjects: 187
Study: 18600443

Group type: EXPERIMENTAL
Intervention: EMG measurements (frontalis, masseter, trapezius muscles)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Skin conductance level (SCL)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Skin temperature
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Relative scores of all parameters
Number of subjects: 60
Study: 15933235

Group type: EXPERIMENTAL
Intervention: Parental consent quality and understanding of the trial
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Parental knowledge of trial details
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Parental decision-making
Number of subjects: 347
Study: 12641528

Group type: EXPERIMENTAL
Intervention: One to eight hours of literature search and retrieval training
Number of subjects: 0

Group type: COMPARATOR
Intervention: No training (control)
Number of subjects: 0
Study: 10331733

Group type: EXPERIMENTAL
Intervention: Rifapentine 150 mg daily
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Rifapentine 300 mg daily
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Rifapentine 600 mg daily
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Rifapentine 600 mg every 3 days
Number of subjects: 23
Study: 7860912

Group type: EXPERIMENTAL
Intervention: Nasal continuous positive airway pressure (10 cm of water)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Time control (no nasal continuous positive airway pressure)
Number of subjects: 16
Study: 1674842

Group type: EXPERIMENTAL
Intervention: Syrup of ipecac (SOI) before activated charcoal (AC)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Activated charcoal (AC) alone
Number of subjects: 70
Study: 7007060

Group type: EXPERIMENTAL
Intervention: Clonidine (0.4 +/- 0.15 mg/day)
Number of subjects: 13
Study: 31768697

Group type: EXPERIMENTAL
Intervention: PF-06439535 plus chemotherapy
Number of subjects: 719

Group type: COMPARATOR
Intervention: bevacizumab-EU plus chemotherapy
Number of subjects: 719
Study: 30988146

Group type: EXPERIMENTAL
Intervention: Tedizolid phosphate 200 mg, intravenously/orally, once daily for 6 days
Number of subjects: 598

Group type: COMPARATOR
Intervention: Linezolid 600 mg, intravenously/orally, twice daily for 10 days
Number of subjects: 598

Group type: EXPERIMENTAL
Intervention: Tedizolid phosphate
Number of subjects: 598

Group type: COMPARATOR
Intervention: Linezolid
Number of subjects: 598
Study: 28237411

Group type: EXPERIMENTAL
Intervention: Disorganization of retinal inner layers (DRIL) assessed by spectral‐domain optical coherence tomography (SDOCT)
Number of subjects: 56
Study: 26830687

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 120

Group type: COMPARATOR
Intervention: Nitrous oxide
Number of subjects: 120
Study: 24381025

Group type: EXPERIMENTAL
Intervention: multifactorial, interdisciplinary intervention targeting frailty characteristics with an individualised home exercise programme prescribed in 10 home visits from a physiotherapist
Number of subjects: 241

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 241
Study: 22654199

Group type: EXPERIMENTAL
Intervention: Stimulus Control Therapy (SCT)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Sleep Restriction Therapy (SRT)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Multicomponent Intervention (MCI)
Number of subjects: 179

Group type: COMPARATOR
Intervention: Wait-list Control Group
Number of subjects: 179
Study: 19818223

Group type: EXPERIMENTAL
Intervention: Sodermix cream
Number of subjects: 15
Study: 17472577

Group type: EXPERIMENTAL
Intervention: Glucose infusion
Number of subjects: 15

Group type: COMPARATOR
Intervention: Mannitol infusion
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Ischaemia
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Reperfusion
Number of subjects: 15
Study: 15279417

Group type: EXPERIMENTAL
Intervention: Topical glaucoma medication (non-selective beta blockers, selective prostaglandin analogues, topical carbonic anhydrase inhibitors)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Natural tears (control group)
Number of subjects: 18
Study: 11961019

Group type: EXPERIMENTAL
Intervention: Modified peritoneal dialysis prescription to achieve a peritoneal creatinine clearance (pCrCl) of 60 L/wk per 1.73 m(2)
Number of subjects: 965

Group type: COMPARATOR
Intervention: Standard PD prescription (4 daily exchanges with 2 L of standard PD solution)
Number of subjects: 965
Study: 9405732

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) replacement therapy
Number of subjects: 19
Study: 7806922

Group type: EXPERIMENTAL
Intervention: Hot water immersion (39.5 degrees C) for 2 hours
Number of subjects: 8

Group type: COMPARATOR
Intervention: Thermoneutral water immersion (34.5 degrees C) for 2 hours
Number of subjects: 8
Study: 2668462

Group type: EXPERIMENTAL
Intervention: Ambulatory blood pressure monitoring
Number of subjects: 75
Study: 817856

Group type: EXPERIMENTAL
Intervention: Propranolol 160 mg/day
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Propranolol 320 mg/day
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Intravenous isoproterenol
Number of subjects: 15
Study: 31220863

Group type: EXPERIMENTAL
Intervention: MUL CM
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: MUL RSM
Number of subjects: 216

Group type: COMPARATOR
Intervention: SKR GM
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: MUL SFM
Number of subjects: 216
Study: 27904912

Group type: EXPERIMENTAL
Intervention: Radial extracorporeal shock wave therapy (rESWT) - 3 sessions, each one week apart, 2,000 rESWT impulses per session, positive energy flux density 0.10-0.16 mJ/mm2
Number of subjects: 105

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 105
Study: 26008634

Group type: EXPERIMENTAL
Intervention: β‐alanine (3.2 g/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: SIT (Sprint Interval Training)
Number of subjects: 24
Study: 22648526

Group type: EXPERIMENTAL
Intervention: H60% (60% maximal oxygen uptake)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: H75% (75% maximal oxygen uptake)
Number of subjects: 10

Group type: COMPARATOR
Intervention: C60% (60% maximal oxygen uptake in 18 °C)
Number of subjects: 10
Study: 21849519

Group type: EXPERIMENTAL
Intervention: Experimental infection with human H3N2 influenza A virus (IAV) in a commercial swine breed.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sera from experimentally inoculated animals.
Number of subjects: 0
Study: 19487194

Group type: EXPERIMENTAL
Intervention: Methylphenidate (dopamine agonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 16869202

Group type: EXPERIMENTAL
Intervention: Topical application of placental-extract gel
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Topical application of placental-extract cream
Number of subjects: 120
Study: 15190718

Group type: EXPERIMENTAL
Intervention: Convex hull hypothesis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Crossing avoidance hypothesis
Number of subjects: 0
Study: 10770191

Group type: EXPERIMENTAL
Intervention: IGF‐I/IGFBP‐3 (2 mg/kg‐day) by continuous sc infusion for 2 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 12
Study: 9432523

Group type: EXPERIMENTAL
Intervention: Methylphenidate (0.3 mg/kg morning dose)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: COMPARATOR
Intervention: Antiepileptic drugs (AEDs) only
Number of subjects: 30
Study: 8260309

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion (CSCI) of morphine 30 micrograms kg‐1 h‐1 after a bolus of 0.1 mg kg‐1 i.v. at the end of the operation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Discontinuous extradural injection of morphine 4 mg at 0, 2, 10 and 18 h after operation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 3856545

Group type: EXPERIMENTAL
Intervention: Prostaglandin F2 alpha (200 micrograms topically applied)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 18
Study: 30827716

Group type: EXPERIMENTAL
Intervention: Physical therapy (PT) on postoperative day 0 (POD 0)
Number of subjects: 394

Group type: COMPARATOR
Intervention: Physical therapy (PT) on postoperative day 1 (POD 1)
Number of subjects: 394
Study: 29539651

Group type: EXPERIMENTAL
Intervention: Linked color imaging (LCI)
Number of subjects: 600

Group type: COMPARATOR
Intervention: High definition white-light imaging (WLI)
Number of subjects: 600
Study: 27894470

Group type: EXPERIMENTAL
Intervention: Sham acupuncture point stimulation with positive verbal suggestions
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control condition (natural history)
Number of subjects: 21
Study: 25438913

Group type: EXPERIMENTAL
Intervention: Younger patients (<75 years)
Number of subjects: 1264

Group type: COMPARATOR
Intervention: Older patients (≥75 years)
Number of subjects: 1264

Group type: EXPERIMENTAL
Intervention: Each increasing decade of life
Number of subjects: 1264
Study: 22117841

Group type: EXPERIMENTAL
Intervention: Autologous bone (AB) chips
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Ossix membrane (OM)
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Combination of AB chips and OM
Number of subjects: 92

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 92
Study: 20222844

Group type: EXPERIMENTAL
Intervention: Hormone therapy (HT)
Number of subjects: 139

Group type: COMPARATOR
Intervention: No hormone therapy (control group)
Number of subjects: 139
Study: 18562790

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (152 mg vitamin C/day and 50 mg vitamin E/day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 16151355

Group type: EXPERIMENTAL
Intervention: Modified liberatory maneuver (LM)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Modified canalith repositioning maneuver (CRP)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Brandt and Daroff's exercise
Number of subjects: 124

Group type: COMPARATOR
Intervention: Vertigo habituation exercises
Number of subjects: 124

Group type: COMPARATOR
Intervention: Sham maneuver
Number of subjects: 124
Study: 12469707

Group type: EXPERIMENTAL
Intervention: Various doses of estrogen (0.3 mg CEE, 0.25 mg 17beta‐estradiol, transdermal patches delivering 20 microg 17beta‐estradiol, intranasal methods delivering 100-400 microg 17beta‐estradiol, 0.625 mg CEE, 0.5 mg 17beta‐estradiol) with or without progestogen.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Progestogen addition to estrogen therapy in women with intact uterus.
Number of subjects: 0
Study: 10943107

Group type: COMPARATOR
Intervention: Statins
Number of subjects: 450000